Sanofi, the maker of a branded hydroxychloroquine drug called Plaquenil, is producing as much as it can to help healthcare systems fighting the pandemic, CEO Paul Hudson told Reuters. But amid the manufacturing push, some employees are having to step aside if they show symptoms.
privacy policy | terms of use | contact us | advertise | pharma jobs | pharma blogs | facebook | twitter
Copyright © 2025,